Isomorphic Labs, an AI-first drug design and development company founded by DeepMind founder Sir Demis Hassabis, has raised £1.6 billion in Series B funding. The latest round of investment will accelerate the UK company’s evolution from pioneering novel AI models to applying them at scale. The financing round is led by Thrive Capital, and includes … Continue reading Sir Demis Hassabis’s Isomorphic Labs raises £1.6bn